medigraphic.com
Sociedad Mexicana de Cirujanos Torácicos Genrales S.C.

2021, Number 2

<< Back Next >>

Rev Mex Cir Torac Gen 2021; 2 (2)

5-year experience in the managment of Solitary Fibrous Tumor of Pleura in a Third Level Hospital

Castro-Roblin LE, Treviño-González M, Cepeda-Ayala GA

Language: Spanish
References: 10
Page: 41-44
PDF size: 186.23 Kb.


ABSTRACT

Introduction and objectives: Solitary fibrous tumors of the pleura comprise less than 5% of all pleural tumors. The objective is to describe the characteristics of the patients treated at the Hospital de Cardiología No. 34 of the Instituto Mexicano del Seguro Social with a diagnosis of pleural solitary fibrous tumor between 2014-2019. Material and methods: The series of 20 patients treated between 2014-2019 at the Cardiology Hospital No. 34 of the Mexican Social Security Institute in Monterrey, Mexico, undergoing open thoracotomy for complete resection of solitary fibrous tumor was reviewed retrospectively. Results: 20 Patients with a mean age of 57.45 years were evaluated, 50.0% of the patients reported asymptomatic, the main clinical data reported by the patients was chest pain in 40.0% of the patients, the origin of the solitary fibrous tumor was located In 75.0% of the cases in the visceral pleura, the parietal pleura was reported as origin in 20.0% of the cases and 5.0% had an origin in the mediastinal pleura. The main side affected was the left, with 70.0%, while the right side was affected in 30.0% of cases. Conclusions: In this study, there are data that are similar to those reported in the literature, including age range, clinical development characteristics and histopathological patterns.


REFERENCES

  1. Lahon B, Mercier O, Fadel E, Ghigna MR, Petkova B, Mussot S et al. Solitary fibrous tumor of the pleura: outcomes of 157 complete resections in a single center. Ann Thorac Surg. 2012; 94(2): 394-400.

  2. Saynak M, Veeramachaneni NK, Hubbs JL, Okumus D, Marks LB. Solitary fibrous tumors of chest: another look with the oncologic perspective. Balkan Med J. 2017; 34(3): 188-199.

  3. Thway K, Ng W, Noujaim J, Jones RL, Fisher C. The current status of solitary fibrous tumor. Int J Surg Pathol. 2016; 24(4): 281-292.

  4. Huang SC, Huang HY. Solitary fibrous tumor: an evolving and unifying entity with unsettled issues. Histol Histopathol. 2019; 34(4): 313-334.

  5. Olson NJ, Linos K. Dedifferentiated solitary fibrous tumor: a concise review. Arch Pathol Lab Med. 2018; 142(6): 761-766.

  6. Supakul R, Sodhi A, Tamashiro CY, Azmi SS, Kadaria D. Solitary fibrous tumor of the pleura: a rare cause of pleural mass. Am J Case Rep. 2015; 16: 854-857.

  7. Fattahi Masuom SH, Bagheri R, Sadrizadeh A, Nouri Dalouee M, Taherian A, Rajaie Z. Outcome of surgery in patients with solitary fibrous tumors of the pleura. Asian Cardiovasc Thorac Ann. 2016; 24(1): 18-22.

  8. Friis RB, Safwat A, Baad-Hansen T, Aggerholm-Pedersen N. Solitary fibrous tumour: a single institution retrospective study and further validation of a prognostic risk assessment system. Clin Oncol. 2018; 30(12): 798-804.

  9. Demicco EG, Wagner MJ, Maki RG, Gupta V, Iofin I, Lazar AJ et al. Risk assessment in solitary fibrous tumors: validation and refinement of a risk stratification model. Mod Pathol. 2017; 30(10): 1433-1442.

  10. Ronchi A, Cozzolino I, Zito Marino F, Accardo M, Montella M, Panarese I et al. Extrapleural solitary fibrous tumor: a distinct entity from pleural solitary fibrous tumor. An update on clinical, molecular and diagnostic features. Ann Diagn Pathol. 2018; 34: 142-150.




2020     |     www.medigraphic.com